FDA Inspection
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc. – FDA Inspection, Jun 3, 2010
Record Details
This FDA Inspection record concerns Sumitomo Pharma America, Inc., with an inspection on June 3, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 3, 2010
- Product Type
- Drugs
View Company Profile
ID · be9e2598-104d-44ae-b3c7-1b9e6e6cd3d7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 668170
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sumitomo Pharma America, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 2, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 5, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 24, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 9, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sumitomo Pharma America, Inc.
- FDA Inspection 1242239 - 2024-08-02
- FDA Inspection 1161579 - 2021-11-05
- FDA Inspection 915063 - 2015-01-23
- FDA Inspection 843011 - 2013-05-24
- FDA Inspection 759431 - 2011-12-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.